| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cat eye syndrome chromosome region | 0.599 | 0.731 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2018 | 2019 | |||||||||
|
cytochrome P450 2D6 | 0.597 | 0.769 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2015 | |||||||||
|
solute carrier family 6 member 4 gene promoter | 0.626 | 0.423 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2012 | 2012 | |||||||||
|
microRNA 143 | 0.462 | 0.885 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2016 | 2019 | |||||||||
|
chromosome 20 open reading frame 181 | 0.479 | 0.885 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
TMX2-CTNND1 readthrough (NMD candidate) | 0.538 | 0.769 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | |||||||||
|
LINC02210-CRHR1 readthrough | 0.570 | 0.692 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 2006 | 2006 | |||||||||
|
cystatin 12, pseudogene | 0.641 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
H3 histone pseudogene 40 | 0.506 | 0.846 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 1 | 2012 | 2012 | |||||||||
|
cataract, anterior polar 1 | 0.568 | 0.731 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
prostate androgen-regulated transcript 1 | 0.483 | 0.885 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
Gilles de la Tourette syndrome | 0.682 | 0.615 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | |||||||||
|
BPI fold containing family A member 4, pseudogene | 0.711 | 0.654 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
microRNA 29c | 0.496 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
loss of heterozygosity, 19, chromosomal region 1 | 0.569 | 0.808 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
pregnancy specific beta-1-glycoprotein 2 | 0.492 | 0.731 | 1.4E-30 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
polycystin 2 like 1, transient receptor potential cation channel | 0.565 | 0.731 | 1.6E-27 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
cytochrome P450 family 2 subfamily D member 6 | 0.437 | 0.885 | 1.1E-25 |
|
group | 0.340 | None | 1.000 | 4 | 0 | 2000 | 2018 | ||||||||
|
notch receptor 4 | 0.534 | 0.731 | 2.1E-23 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
cytochrome P450 family 2 subfamily C member 19 | 0.467 | 0.846 | 6.5E-20 |
|
group | 0.020 | None | 1.000 | 2 | 0 | 2000 | 2011 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
corticotropin releasing hormone receptor 2 | 0.584 | 0.731 | 8.5E-17 |
|
group | 0.040 | None | 1.000 | 4 | 2 | 2006 | 2019 |